S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
Critical asset just had biggest fall on record (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
OTCMKTS:CSPCY

CSPC Pharmaceutical Group (CSPCY) Stock Price, News & Analysis

C$3.03
-0.20 (-6.19%)
(As of 02/28/2024 ET)
Today's Range
C$3.02
C$3.05
50-Day Range
C$2.85
C$3.69
52-Week Range
C$2.63
C$4.46
Volume
7,221 shs
Average Volume
31,956 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. It provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson's disease; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; and Keaili for breast cancer. The company also offers Shuluoke, Nuomoling, Weihong, and Xinweihong for various infections; Xuanning for hypertension; Encun to prevent atherosclerotic thrombosis events; Qixiao to treat upper respiratory tract infection; Linmeixin and Shuanglexin for diabetes; Gubang and Gubangjia to treat osteoporosis in postmenopausal women; and Gaoshunsong for arthritis, osteoarthritis, ankylosing spondylitis, frozen shoulder, bursuitis, tenosynovitis, acute gout, dysmenorrhea, toothache and postoperative pain, low back pain, sprain, strain, and other soft tissue injuries. In addition, it provides Debixin for various ulcer; Qimaite for acute and chronic pains; antibiotics, vitamin C, and caffeine APIs; functional food and glucose products; and healthcare services. The company has a strategic partnership with Pfizer Inc. to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the People's Republic of China.

CSPCY Stock Price History

CSPCY Stock News Headlines

CSPC Pharmaceutical Group Ltd (CVG.SG)
CSPC Pharmaceutical Group Ltd
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
CSPC Pharmaceutical Group Ltd 01093
CSPC Pharmaceutical Group Ltd. ADR
China OKs its first mRNA vaccine, from drugmaker CSPC
See More Headlines
Receive CSPCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSPC Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
Current Symbol
OTCMKTS:CSPCY
CIK
N/A
Fax
N/A
Employees
24,837
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Dongchen Cai (Age 70)
    Executive Chairman
    Comp: $2.73M
  • Mr. Cuilong Zhang (Age 55)
    Vice-Chairman & CEO
    Comp: $1.48M
  • Mr. Chunlei Li (Age 48)
    Executive Director & Chief Scientist
    Comp: $1.07M
  • Mr. Kin Man Chak (Age 58)
    Executive Director
    Comp: $733.28k
  • Mr. Weidong Pan (Age 54)
    Executive Director
    Comp: $773.16k
  • Mr. Huaiyu Wang (Age 61)
    Executive Director
    Comp: $887.94k
  • Mr. Zhenguo Wang (Age 54)
    Executive Director
    Comp: $768.58k
  • Dr. Qingxi Wang Ph.D. (Age 58)
    Executive Director
    Comp: $633.65k
  • Dr. Hao Jiang (Age 41)
    Executive Director
    Comp: $704.52k
  • Mr. Tai On Lo CPA (Age 70)
    Company Secretary














CSPCY Stock Analysis - Frequently Asked Questions

How have CSPCY shares performed in 2024?

CSPC Pharmaceutical Group's stock was trading at C$3.69 at the beginning of 2024. Since then, CSPCY stock has decreased by 17.9% and is now trading at C$3.03.
View the best growth stocks for 2024 here
.

Are investors shorting CSPC Pharmaceutical Group?

CSPC Pharmaceutical Group saw a increase in short interest in February. As of February 15th, there was short interest totaling 3,600 shares, an increase of 89.5% from the January 31st total of 1,900 shares. Based on an average daily trading volume, of 69,300 shares, the days-to-cover ratio is currently 0.1 days.
View CSPC Pharmaceutical Group's Short Interest
.

How often does CSPC Pharmaceutical Group pay dividends? What is the dividend yield for CSPC Pharmaceutical Group?

CSPC Pharmaceutical Group announced a dividend on Thursday, August 24th. Shareholders of record on Friday, September 8th will be paid a dividend of 0.0572 per share on Thursday, October 26th. The ex-dividend date of this dividend is Thursday, September 7th.
Read our dividend analysis for CSPCY
.

How do I buy shares of CSPC Pharmaceutical Group?

Shares of CSPCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CSPCY) was last updated on 2/29/2024 by MarketBeat.com Staff